FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009919478> ?p ?o ?g. }

• W2009919478 endingPage "54" @default.
• W2009919478 startingPage "44" @default.
• W2009919478 abstract "TeratologyVolume 66, Issue 1 p. 44-54 Commentary Inertia on folic acid fortification: Public health malpractice Godfrey P. Oakley Jr, Corresponding Author Godfrey P. Oakley Jr [email protected] Department of Epidemiology, Rollins School of Public Health of Emory University, Atlanta, Georgia 30322Dept. of Epidemiology, Rollins School of Public Health of Emory University, Atlanta, GA 30322Search for more papers by this author Godfrey P. Oakley Jr, Corresponding Author Godfrey P. Oakley Jr [email protected] Department of Epidemiology, Rollins School of Public Health of Emory University, Atlanta, Georgia 30322Dept. of Epidemiology, Rollins School of Public Health of Emory University, Atlanta, GA 30322Search for more papers by this author First published: 28 June 2002 https://doi.org/10.1002/tera.10079Citations: 27AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat LITERATURE CITED Agamanolis DP, Chester EM, Victor M, Kark JA, Hines JD, Harris JW. 1976. Neuropathology of experimental vitamin B12 deficiency in monkeys. Neurology 26: 905–914. Ames BN. 2001. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res 475: 7–20. Berry RJ, Li Z, Erickson JD, Moore CA, Wang H, Mulinare J, Zhao P, Wong L-YC, Gindler J, Hong S-X, Correa A. 1999. Prevention of neural-tube defects with folic acid in China. China–US collaborative project for neural tube defect prevention. N Engl J Med 341: 1485–1490. Bostom AG, Rosenberg IH, Silbershatz H, Jacques PF, Selhum J, D'Agostino RB, Wilson PW, Wolf PA. 1999. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham study. Ann Intern Med 131: 355–355. Bostom AG, Selhub J, Jacques PF, Rosenberg IH. 2001. Power shortage: clinical trial testing the “homocysteine hypothesis” against a background of folic acid-fortified cereal grain flour. Ann Intern Med 135(2): 133–137. Botto LD, Moore CA, Khoury MJ, Erickson JD. 1999. Neural-tube defects. N Engl J Med 341: 1509–1519. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. 1995. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274: 1049–1057. Centers for Disease Control and Prevention. 1992. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep 41: 1–7. Centers for Disease Control and Prevention. 2000. Folate status in women of childbearing age—United States, 1999. MMWR Morb Mortal Wkly Rep 49: 962–965. Clarke R, Armitage J. 2000. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements. Semin Thromb Hemost 26: 341–348. Committee on Medical Aspects of Food and Nutrition Policy. 2000. Folic acid and the prevention of disease. Report of the Committee on Medical Aspects of Food and Nutrition Policy Reports on Health and Social Subjects. 50. London: The Stationery Office. p 1–101. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327: 1832–1835. Daly LE, Kirke PH, Molloy A, Weir DG, Scott JM. 1995. Folate levels and neural tube defects. Implications for prevention. JAMA 274: 1698–1702. deBree A, Vershuren WMM, Blom HJ, Kromhout D. 2001. Association between B vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20–65 y. Am J Clin Nutr 73: 1027–1033. Dickinson CJ. 1995. Does folic acid harm people with vitamin B12 deficiency? QJM 88: 357–364. Fenech M. 2001. The role of folic acid and vitamin B12 in genomic stability of human cells. Mutat Res 475: 57–67. Food and Drug Administration. 1996. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Regist 61: 8781–8807. Food and Nutrition Board IoM. 1998. Dietary reference intakes for thiamin, riboflavin, niacin, folate, vitamin B12, pantothenic acid, biotin, and choline: a report of the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins and Choline and Subcommittee on Upper Reference Levels for Nutrients. Washington DC: National Academy Press. Freire WB, Hertrampf E, Cortes F. 2000. Effect of folic acid fortification in Chile: preliminary results. Eur J Pediatr Surg 10: 42–43. Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, Fuchs C, Rosner, BA, Speizer FE, Willett WC. 1998. Multivitamin use, folate and colon cancer in women in the Nurses' Health Study. Ann Intern Med 129: 517–524. Graham IM, Daly, LE, Refsum HM, Robinson K, Brattström LE, Ueland PM, Palma-Reis RJ, Boers GHJ, Sheahan RG, Israelsson B, Ulterwaal CS, Meleady R, McMaster D, Verhoef P, Witterman J, Rubba P, Bellet H, Wautrecht JC, de Valk Hw, Luis ACS, Parrot-Roulaud FM, Tan KS, Higgins I, Garcon D, Medrano MJ, Candito M, Evans AE, Andria G. 1997. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277: 1775–1781. Hill BA. 1965. The environment and disease: association of causation? Proc R Soc Med 58: 295–300. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. 2001. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285: 2981–2986. Indian Council of Medical Research Collaborating Centres and Central Technical Coordinating Unit I, New Delhi. 2000. Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian J Med Res 112: 206–211. Jacques P, Bostom AG, Wilson PWF, Rich S, Rosenberg I, Selhub J. 2001. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 73: 613–621. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. 1999. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 340: 1449–1454. Laurence KM, James N, Miller MH, Tennant GB, Campbell H. 1981. Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. Br Med J 282: 1509–1511. Lawrence JM, Petitti DB, Watkins M, Umekubo MA. 1999. Trends in serum folate after food fortification. Lancet 354: 915–916. Lewis CA, Pancharuniti N, Sauberlich HE. 1992. Plasma folate adequacy as determined by homocysteine level. Ann NY Acad Sci 669: 360–362. Lindenbaum J, Healton EB, Savage DG, Brust JCM, Garrett TJ, Podell ER, Marcell PD, Stabler SP, Allen RH. 1988. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 318: 1720–1728. Mark SD, Wang W, Fraumeni JF, Li JY, Tayler PR, Wang GQ, Guo W, Dawsey SM, Bing L, Blot WJ. 1996. Lowered risks of hypertension and cerebrovascular disease after vitamin/mineral supplementation: the Linxian Nutrition Intervention Trial. Am J Epidemiol 143: 658–664. Martin JA, Smith BL, Mathews TJ, Ventura MA. 1999. Births and deaths: preliminary data for 1998. Natl Vital Stat Rep 47: 1–45. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 338: 131–137. Quiniivan EP, McPartlin J, McNulty H, Ward M, Strain JJ, Weir DG, Scott JM. 2002. Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet 359: 227–228. Raats M, Thorpe L, Hurren C, Elliott K. 1998. Changing preconceptions: the HEA Folic Acid Campaign, 1995–1998. London: Health Education Authority 2. Riddell LJ, Chisholm A, Williams S, Mann JI. 2000. Dietary strategies for lowering homocysteine concentrations. Am J Clin Nutr 71: 1448–1454. Rodrigues LC, Smith PG. 1999. Use of the case-control approach in vaccine evaluation: efficacy and adverse effects. Epidemiol Rev 21: 56–72. Rydlewicz A, Simpson J, Taylor R, Bond C, Golden M. 2002. The effect of folic acid supplementation on plasma homocysteine in an elderly population. QJM 95: 27–35. Schnyder G, Roffi M, Pin R, Flammer Y, Lange H, Eberli FR, Meier B, Turi ZG, Hess OM. 2001. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 345: 1593–1600. Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, Wright JD, Johnson CL. 1999. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991–1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Int Med 131: 331–339. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. 1993. Vitamin status and intake as primary determinants of homocystinemia in an elderly population. JAMA 270: 2693–2698. Smithells RW, Nevin NC, Seller MJ, Sheppard S, Harris R, Read AP, Fielding DW, Walker S, Schorah CJ, Wild J. 1983. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1: 1027–1031. Tice JA, Ross E, Coxson PG, Rosenberg I, Weinstein MC, Hunink MG, Goldman PA, Williams L, Goldman L. 2001. Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease: effect of grain fortification and beyond. JAMA 286: 936–943. Vilter CF, Vilter RW, Spies TD. 1947. The treatment of pernicious and related anemias with synthetic folic acid: observations on maintenance of normal hematologic status and on occurrence of combined system disease at the end of one year. J Lab Clin Med 32: 262–273. Wald NJ, Law MR, Morris JK, Wald DS. 2001. Quantifying the effect of the folic acid. Lancet 358: 2069–2073. Wharton B, Booth I. 2001. Fortification of flour with folic acid. A controlled field trial is needed. BMJ 323: 1198–1199. Citing Literature Volume66, Issue1July 2002Pages 44-54 ReferencesRelatedInformation" @default.
• W2009919478 created "2016-06-24" @default.
• W2009919478 creator A5034538543 @default.
• W2009919478 date "2002-06-28" @default.
• W2009919478 modified "2023-09-27" @default.
• W2009919478 title "Inertia on folic acid fortification: Public health malpractice" @default.
• W2009919478 cites W1824816810 @default.
• W2009919478 cites W1971092152 @default.
• W2009919478 cites W1975357252 @default.
• W2009919478 cites W1986667412 @default.
• W2009919478 cites W1986795920 @default.
• W2009919478 cites W1987947496 @default.
• W2009919478 cites W1995781460 @default.
• W2009919478 cites W1997067835 @default.
• W2009919478 cites W2010098219 @default.
• W2009919478 cites W2011006722 @default.
• W2009919478 cites W2020802956 @default.
• W2009919478 cites W2030111890 @default.
• W2009919478 cites W2032084625 @default.
• W2009919478 cites W2033918343 @default.
• W2009919478 cites W2045297515 @default.
• W2009919478 cites W2064912482 @default.
• W2009919478 cites W2071487095 @default.
• W2009919478 cites W2082514717 @default.
• W2009919478 cites W2087461651 @default.
• W2009919478 cites W2089205356 @default.
• W2009919478 cites W2098453804 @default.
• W2009919478 cites W2102291836 @default.
• W2009919478 cites W2106443998 @default.
• W2009919478 cites W2115353211 @default.
• W2009919478 cites W2121099849 @default.
• W2009919478 cites W2121535578 @default.
• W2009919478 cites W2132109062 @default.
• W2009919478 cites W2165985110 @default.
• W2009919478 cites W2239542423 @default.
• W2009919478 cites W2322037963 @default.
• W2009919478 cites W2325417132 @default.
• W2009919478 cites W2326469489 @default.
• W2009919478 cites W4206832593 @default.
• W2009919478 cites W4237533794 @default.
• W2009919478 doi "https://doi.org/10.1002/tera.10079" @default.
• W2009919478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12115780" @default.
• W2009919478 hasPublicationYear "2002" @default.
• W2009919478 type Work @default.
• W2009919478 sameAs 2009919478 @default.
• W2009919478 citedByCount "36" @default.
• W2009919478 countsByYear W20099194782012 @default.
• W2009919478 countsByYear W20099194782013 @default.
• W2009919478 countsByYear W20099194782014 @default.
• W2009919478 countsByYear W20099194782015 @default.
• W2009919478 countsByYear W20099194782020 @default.
• W2009919478 countsByYear W20099194782023 @default.
• W2009919478 crossrefType "journal-article" @default.
• W2009919478 hasAuthorship W2009919478A5034538543 @default.
• W2009919478 hasConcept C126322002 @default.
• W2009919478 hasConcept C138816342 @default.
• W2009919478 hasConcept C142724271 @default.
• W2009919478 hasConcept C17744445 @default.
• W2009919478 hasConcept C185592680 @default.
• W2009919478 hasConcept C198211336 @default.
• W2009919478 hasConcept C199539241 @default.
• W2009919478 hasConcept C2776798817 @default.
• W2009919478 hasConcept C2992130864 @default.
• W2009919478 hasConcept C31903555 @default.
• W2009919478 hasConcept C71924100 @default.
• W2009919478 hasConcept C99454951 @default.
• W2009919478 hasConceptScore W2009919478C126322002 @default.
• W2009919478 hasConceptScore W2009919478C138816342 @default.
• W2009919478 hasConceptScore W2009919478C142724271 @default.
• W2009919478 hasConceptScore W2009919478C17744445 @default.
• W2009919478 hasConceptScore W2009919478C185592680 @default.
• W2009919478 hasConceptScore W2009919478C198211336 @default.
• W2009919478 hasConceptScore W2009919478C199539241 @default.
• W2009919478 hasConceptScore W2009919478C2776798817 @default.
• W2009919478 hasConceptScore W2009919478C2992130864 @default.
• W2009919478 hasConceptScore W2009919478C31903555 @default.
• W2009919478 hasConceptScore W2009919478C71924100 @default.
• W2009919478 hasConceptScore W2009919478C99454951 @default.
• W2009919478 hasIssue "1" @default.
• W2009919478 hasLocation W20099194781 @default.
• W2009919478 hasLocation W20099194782 @default.
• W2009919478 hasOpenAccess W2009919478 @default.
• W2009919478 hasPrimaryLocation W20099194781 @default.
• W2009919478 hasRelatedWork W1911766642 @default.
• W2009919478 hasRelatedWork W1946008530 @default.
• W2009919478 hasRelatedWork W2085943176 @default.
• W2009919478 hasRelatedWork W2089513431 @default.
• W2009919478 hasRelatedWork W2103734084 @default.
• W2009919478 hasRelatedWork W2104010829 @default.
• W2009919478 hasRelatedWork W2120230375 @default.
• W2009919478 hasRelatedWork W2412334414 @default.
• W2009919478 hasRelatedWork W3000196268 @default.
• W2009919478 hasRelatedWork W3070521311 @default.
• W2009919478 hasVolume "66" @default.
• W2009919478 isParatext "false" @default.
• W2009919478 isRetracted "false" @default.
• W2009919478 magId "2009919478" @default.
• W2009919478 workType "article" @default.